Traditional West European and North American Pharmaceutical Ingredient Manufacturers have been Replaced by Indian Pharmaceutical Ingredient Manufacturers and Chinese Pharmaceutical Manufacturers Creating Potential for Dangerous Adulterated Drugs and Pharmaceutical Supply Chain Fraud by International Pharmaceutical Supply Chain Fraud Whistleblower Reward Lawyer, International Adulterated Active Pharmaceutical Ingredient Whistleblower Lawyer, and International Pharmaceutical Excipient Whistleblower Reward Lawyer Jason S. Coomer

Traditional West European and North American Pharmaceutical Ingredient Manufacturers have been Replaced by Indian Pharmaceutical Ingredient Manufacturers and Chinese Pharmaceutical Manufacturers Creating Potential for Dangerous Adulterated Drugs and Pharmaceutical Supply Chain Fraud by International Pharmaceutical Supply Chain Fraud Whistleblower Reward Lawyer, International Adulterated Active Pharmaceutical Ingredient Whistleblower Lawyer, and International Pharmaceutical Excipient Whistleblower Reward Lawyer Jason S. Coomer 

The pharmaceutical ingredient market including pharmaceutical excipient manufacturers, pharmaceutical intermediate manufacturers, and active pharmaceutical ingredient (API) manufacturers has become very competitive with many international pharmaceutical ingredient producers.  As large pharmaceutical companies and the pharmaceutical industry compete to lower the cost of drug production, the drug companies are seeking the cheapest pharmaceutical ingredients that they can locate.  As such, many of the drug companies driven by profits and lower costs are moving their API manufacturing, pharmaceutical excipient suppliers, and pharmaceutical intermediate suppliers from Western countries to India and China.  Unfortunately, in some situations the pharmaceutical ingredient manufacturer is not properly regulated and the drug ingredients are contaminated, not produced under good manufacturing practices, contain dangerous foreign substances, or are otherwise adulterated.

International Whistleblowers that are aware of these adulterated pharmaceutical ingredients are needed to blow the whistle on quality assurance fraud, adulterated drugs, and pharmaceutical supply chain fraud.  As such, whistleblower reward laws are in place that offer large potential rewards and whistleblower protections to whistleblowers that blow the whistle on adulterated pharmaceutical ingredients, adulterated medicine, adulterated drugs, contaminated medical supplies, and defective medical devices.

 Traditional West European and North American API Manufacturers have been Replaced by Indian API Manufacturers and Chinese API Manufacturers

The overall API market was valued at $101.08 billion in 2010, and is expected to grow at a CAGR of 7.9% from 2011 to 2016. The market share held by Indian API manufacturers in the global API merchant market (generic APIs and branded/innovator APIs) was 6.5% in 2005, 12.0% in 2010, and is expected to increase to 22.0% by 2015. India’s share of the global generic API merchant market has increased from 13.5% in 2005 to 22.1% in 2010 and is expected to increase to 33.3% by 2015. Export sales of generic APIs from India increased at an average of 18.9% between 2005–2010 compared with an annual average of 15.9% to the country’s domestic market.  India is expected to be the fastest growing API supplier during the next five years and will keep its position above China.

The market share held by Chinese companies in the global API merchant market (generic APIs and branded/innovative APIs) has risen from 14.2% in 2005 to 19% in 2010. The market share held by Chinese companies in the global generic API merchant market increased from 31.1% in 2005 to 35.6% in 2010. Although China remains the largest API supplier on a global basis, growth rates from 2005–2010 of Chinese API suppliers were less than those of Indian suppliers. 

Traditional West European and North American Excipient Manufacturers have been Replaced by Indian Excipient Manufacturers and Chinese Excipient Manufacturers 

Pharmaceutical excipients play an important role in pharmaceutical formulations by adding functionality or by facilitating the processing of a drug product.  Recent trends in the pharmaceutical excipient manufacturer industry include: geographic expansion and select investment in emerging markets.  In other word excipient manufacturing like API manufacturing and pharmaceutical intermediate manufacturing are moving from western countries to India and China.

The global market for excipients totaled $4.9 billion in 2011. That value is projected to reach more than $6.7 billion in 2016 after increasing at a five-year compound annual growth rate (CAGR) of 6.5%.   The global excipients market can be broken down by material type into three segments – organic, inorganic, and USP (U.S. pharmaceutical) water.

International Adulterated Drug Supply Chain Whistleblower Reward Lawyer, International Pharmaceutical Supply Chain Fraud Whistleblower Lawyer, Medical Device Supply Chain Illegal Kickback Lawyer, Medicine Supply Chain Whistleblower Reward Lawyer, Medicine Supply Chain Fraud Lawyer, and Pharmaceutical Supply Chain Foreign Corrupt Practices Act Lawyer

 

International Whistleblowers along the pharmaceutical supply chain and other health care professionals are being offered large potential rewards to blow the whistle on adulterated pharmaceutical ingredients, adulterated medicine, adulterated drugs, contaminated medical supplies, and defective medical devices.  For more information on International Adulterated Drug Supply Chain Whistleblower Reward Lawsuits, please feel free to go to the following web page: International Adulterated Drug Supply Chain Whistleblower Reward Lawsuit Information.